Comparable changes in synaptic dopamine induced by methylphenidate and by cocaine in the baboon brain

Synapse

Volumn 31, Issue 1, 1999, Pages 59-66

  Volkow, N D ^a,b   Fowler, J S ^a   Gatley, S J ^a   Dewey, S L ^a   Wang, G J ^a   Logan, J ^a   Ding, Y S ^a   Franceschi, D ^a   Gifford, A ^a   Morgan, A ^a   Pappas, N ^a   King, Payton ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

11C raclopride; Dopamine D2 receptors; Dopamine transporters; Positron emission tomography (PET); Reinforcement

Indexed keywords

COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; METHYLPHENIDATE; RACLOPRIDE; RADIOLIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; BRAIN SLICE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC TRANSMISSION; DRUG EFFICACY; IMAGE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECEPTOR OCCUPANCY; REINFORCEMENT; SYNAPTIC TRANSMISSION;

ANIMALS; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; FEMALE; METHYLPHENIDATE; PAPIO; RADIOLIGAND ASSAY; SYNAPSES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032962112     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199901)31:1<59::AID-SYN8>3.0.CO;2-Y     Document Type: Article

References (47)

1. Aoyama TN, Kotaki HN, Sawada YN, Iga T. 1996. Pharmacokinetics and pharmacodynamics of methylphenidate enantiomers in rats. Psychopharmacology 127:117-122.
2. Bergman J, Madras BK, Johnson SE, Spealman RD. 1989. Effects of cocaine and related drugs in nonhuman primates. III. Self administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155.
3. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D. 1997. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 194:2569-2574.
4. Butcher SP, Liptrot J, Aburthnott GW. 1991. Characterization of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis. Neurosci Lett 122:245-248.
5. 11C-methyl]-benztropine. Synapse 5:213-223.
6. 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse 13:350-356.
7. Di Chiara G, Imperato A. 1988. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278.
8. 11C]dl-threo-methylphenidate for the presynaptic dopaminergic neuron. Synapse 18:152-160.
9. 11C]d-threo and 1-threo-methylphenidate in the human and baboon brain. Psychopharmacology 131:71-78.
10. Egilmez Y, Jung ME, Lane JD, Emmett-Oglesby MW. 1995. Dopamine release during cocaine self administration: Effects of SCH23390. Brain Res 701:142-150.
11. Evans SM, Cone EJ, Henningfield JE. 1996. Arterial and venous cocaine plasma concentrations in humans: Relationship to route of administration, cardiovascular effects and subjective effects. J Pharmacol Exp Ther 279:1345-1356.
12. 11C]d-threomethylphenidate for estimating dopamine transporter occupancy by cocaine in vivo. Synapse 28:111-116.
13. Gatley SJ, Pan D, Chen R, Charurvedi G, Ding Y-S. 1996. Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci 58:231-239.
14. Gifford A, Gatley SJ, Ashby CR. 1996. Endogenously released dopamine inhibits the binding of dopaminergic PET and SPECT ligands in superfused rat striatal slices. Synapse 22:232-238.
15. Hooks SM, Colvin AC, Juncos JL, Justice JB. 1992. Individual differences in basal and cocaine-stimulated extracellular dopamine in the nucleus accumbens using quantitative microdialysis. Brain Res 587:306-312.
16. Howell LL, Byrd LD. 1992. Enhanced sensitivity to the behavioral effects of cocaine after chronic administration of D2-selective dopamine antagonists in the squirrel monkey. J Pharm Exp Ther 262:907-915.
17. Hurd YL, Ungerstedt U. 1989. Cocaine: An in vivo microdialysis evaluation of its acute actions on dopamine transmission in rat striatum. Synapse 3:48-54.
18. Hurd YL, Kehr J, Ungerstedt U. 1988. In vivo microdialysis as a technique to monitor drug transport: Correlations of extracellular cocaine levels and dopamine overflow in the rat brain. J Neurochem 51:1314-1316.
19. Izenwasser S, Werling LL, Cox BM. 1990. Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle and medial prefrontal cortex. Brain Res 520:303-309.
20. Johanson CE, Shuster CR. 1975. A choice procedure for drug reinforcers: Cocaine and methylphenidate in the rhesus monkey. J Pharmacol Exp Ther 193:676-688.
21. Kuczenski R, Segal DS, Aizenstein ML. 1991. Amphetamine, cocaine and fencamfamine: Relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J Neurosci 11:2703-2712.
22. Laruelle M, Abi-Darham A, Van Dick CH, Gil R, D'Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB. 1996. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci 93:9235-9240.
23. Laruelle M, D'Souza CD, Baldwin RM, Abi-Dargham A, Kanes SJ, Fingado CL, Seibyl JP, Zoghbi SS, Bowers MB, Jatlow P, Charney DS, Innis RB. 1997. Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology 17:162-174.
24. 11C-methyl]-(1)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10:740-747.
25. Logan J, Volkow ND, Fowler JS, Wang G-J, Dewey SL, MacGregor R, Schlyer D, Gatley SJ, Pappas N, King P, Hitzemman R, Vitkun S. 1994. Effects of blood flow on [11C]raclopride binding in the brain: Model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab 14:995-1010.
26. Mach RH, Nader MA, Ehrenkaufer RL, Line SW, Smith CR, Gage HD, Morton TE. 1997. Use of positron emission tomography to study the dynamics of psychostimulant-induced dopamine release. Pharmacol Biochem Behav 57:477-486.
27. 3H]Cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther 251:131-141.
28. Moghaddam B, Bunney BS. 1989. Differential effects of cocaine on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. Synapse 4:156-161 1989.
29. NIDA-CEWG (National Institute on Drug Abuse, Community Epidemiology Work Group) (1995) Epidemiologic Trends in Drug Abuse. DHHS Pub. No. 95-3988 (NIH), Washington DC.
30. Pan WH, Lai YJ, Chen NH. 1995. Differential effects of chloral hydrate and pentobarbital sodium on a cocaine level and its catecholamine response in the medial prefrontal cortex: A comparison with conscious rats. J Neurochem 64:2653-2659.
31. Parran TV, Jasinski DR. 1991. Intravenous methylphenidate abuse: Prototype for prescription drug abuse. Arch Intern Med 151:781-783.
32. Patrick KS, Caldwell RW, Ferris RM, Breese GR. 1987. Pharmacology of the enantiomers of threo-methylphenidate. J Pharmacol Exp Ther 241:152-158.
33. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. 1987. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223.
34. 11C]raclopride at dopamine receptors in human subjects. Am J Psychiatry 154:1209-1213.
35. Seeman P, Guan HC, Niznik HB. 1996. Endogenous dopamine lowers the dopamine D2 receptor density as measured by 3H raclopride: Implications for positron emission tomography of the human brain. Synapse 3:96-97.
36. Stathis M, Scheffel U, Lever SZ, Boja JW, Carroll FI, Kuhar MJ. 1995. Rate of binding of various inhibitors at the dopamine transporter in vivo. Psychopharmacology 119:376-384.
37. Strange P. 1997. Biochemical characterization of dopamine receptors. In: The Dopamine Receptors. K.A. Neve and R.L. Neve, eds. Humana Press, Totowa NJ, pp. 3-26.
38. 11C raclopride binding in the human brain. J Nucl Med 34:609-613.
39. 11C]raclopride in the human brain. Synapse 16:255-262.
40. Volkow ND, Ding U, Fowler JS, Wang GJ, Logan J, Gatley JS, Dewey SL, Ashby C, Lieberman J, Hitzemann R, Wolf AP. 1995a. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain. Arch Gen Psychiatry 52:456-463.
41. Volkow ND, Fowler JS, Logan J, Gatley SJ, Dewey SL, MacGregor RR, Schlyer DJ, Pappas N, King P, Wolf AP. 1995b. Carbon-11-cocaine binding compared at sub-pharmacological and pharmacological doses: A PET study. J Nucl Med 36:1289-1297.
42. Volkow ND, Wang G-J, Fowler JS, Gatley SJ, Ding Y-S, Logan J, Dewey SL, Hitzemann R, Lieberman J. 1996a. Relationship between psychostimulant induced high and dopamine transporter occupancy. Proc Natl Acad Sci USA 93:10388-10392.
43. Volkow ND, Gatley SJ, Fowler JS, Logan J, Fischman M, Gifford AN, Pappas N, King P, Ding Y-S, Wang G-J. 1996b. Cocaine doses equivalent to those abused by humans occupy most of the dopamine transporters. Synapse 24:339-402.
44. Volkow ND, Wang G-J, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Gatley SJ, Pappas N, Hitzemann R, Shea K. 1997a. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386:827-830.
45. Volkow ND, Wang G-J, Fowler S, Logan J, Hitzemann RJ, Chen AD, Pappas N. 1997b. Decreased striatal dopaminergic responsiveness in detoxified cocaine dependent subjects. Nature 386:830-833.
46. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding Y-S, Dewey SL, Hitzemann R, Gifford A, and Pappas NR. (in press). Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self reports of "high." J Pharmacol Exp Therapeutics
47. Wang G-J, Volkow ND, Hitzemann RJ, Wong C, Angrist B, Burr G, Pascani K, Pappas N, Lu A, Cooper T, Lieberman JA. 1997. Behavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusers. Eur Addict Res 3:49-54.